BioDiem Ltd - Strategic SWOT Analysis Review

BioDiem Ltd - Strategic SWOT Analysis Review

  • Products Id :- GDPH61751SA
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

BioDiem Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.


BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company's product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.

BioDiem Ltd Key Recent Developments

Mar 17,2017: BioDiem Announces its Half Year Results

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

BioDiem Ltd-Key Facts 5

BioDiem Ltd-Key Employees 6

BioDiem Ltd-Key Employee Biographies 7

BioDiem Ltd-Major Products and Services 8

BioDiem Ltd-History 9

BioDiem Ltd-Company Statement 11

BioDiem Ltd-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

BioDiem Ltd-Business Description 14

BioDiem Ltd-Corporate Strategy 15

BioDiem Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

BioDiem Ltd-Strengths 16

BioDiem Ltd-Weaknesses 17

BioDiem Ltd-Opportunities 18

BioDiem Ltd-Threats 19

BioDiem Ltd-Key Competitors 20

Section 3-Company's Lifesciences Financial Deals and Alliances 21

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22

BioDiem Ltd, Recent Deals Summary 23

Section 4-Company's Recent Developments 24

Mar 17, 2017: BioDiem Announces its Half Year Results 24

Section 5-Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Figures

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22

List of Tables

BioDiem Ltd, Key Facts 5

BioDiem Ltd, Key Employees 6

BioDiem Ltd, Key Employee Biographies 7

BioDiem Ltd, Major Products and Services 8

BioDiem Ltd, History 9

BioDiem Ltd, Subsidiaries 12

BioDiem Ltd, Key Competitors 20

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21

BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22

BioDiem Ltd, Recent Deals Summary 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Therapix Biosciences Ltd

MedImmune LLC

Altimmune Inc

AdAlta Ltd

BioDiem Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]